Trexquant Investment LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 164 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,486,000
-4.5%
26,551
+129.0%
0.05%
-58.1%
Q3 2021$1,556,000
+55.1%
11,596
-7.2%
0.12%
+34.8%
Q1 2021$1,003,000
+12.7%
12,493
-72.1%
0.09%
+61.4%
Q3 2020$890,000
+21.4%
44,753
+28.3%
0.06%
+11.8%
Q2 2020$733,000
+134.9%
34,882
+36.8%
0.05%
+121.7%
Q1 2020$312,000
+42.5%
25,501
+70.7%
0.02%
+76.9%
Q4 2019$219,000
+31.9%
14,940
+20.0%
0.01%
-7.1%
Q3 2019$166,000
-10.8%
12,450
+9.6%
0.01%
-17.6%
Q2 2019$186,000
-66.5%
11,357
-44.1%
0.02%
-55.3%
Q2 2018$555,00020,3010.04%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders